Table 1 Psychopathological characteristics at baseline, at 3 months and clinical changes during the follow-up period. Comparison between aripiprazole and risperidone.
Total (N = 30) | Statistics | p | Aripiprazole (n = 16) | Risperidone (n = 14) | Statistics | p | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |||||
CGI | ||||||||||
Baseline | 6.5 | 0.6 | 6.56 | 0.51 | 6.43 | 0.65 | t = 0.63c | 0.532 | ||
3 Months | 1.8 | 1.2 | 1.63 | 1.20 | 2.00 | 1.24 | ||||
3-Month change from baseline | −4.7 | 1.2 | z = 4.83a | 0.000 | −4.90 | 0.30 | −4.47 | 0.33 | F = 0.96d | 0.336 |
YMRS | ||||||||||
Baseline | 13.8 | 6.2 | 14.25 | 7.24 | 13.29 | 5.01 | t = 0.42c | 0.679 | ||
3 Months | 1.2 | 2.3 | 1.56 | 2.63 | 0.79 | 1.93 | ||||
3-Month change from baseline | −12.6 | 6.5 | z = 4.78a | 0.000 | −12.25 | 0.59 | −13.00 | 0.63 | F = 0.75d | 0.394 |
CDSS | ||||||||||
Baseline | 1.5 | 3.0 | 2.06 | 3.82 | 0.86 | 1.75 | t = 1.08c | 0.288 | ||
3 Months | 1.2 | 2.3 | 1.19 | 2.34 | 1.14 | 2.25 | ||||
3-Month change from baseline | −0.3 | 3.7 | z = 0.35a | 0.724 | −0.34 | 0.59 | −0.32 | 0.63 | F = 0.00d | 0.985 |
BPRS | ||||||||||
Baseline | 70.3 | 15.0 | 69.06 | 16.08 | 71.85 | 13.95 | t = − 0.49c | 0.627 | ||
3 Months | 29.9 | 7.1 | 29.06 | 7.07 | 30.92 | 7.48 | ||||
3-Month change from baseline | −40.4 | 15.2 | t = 14.32b | 0.000 | −41.13 | 1.81 | −39.53 | 2.01 | F = 0.35d | 0.561 |
SAPS | ||||||||||
Baseline | 15.9 | 4.2 | 15.63 | 3.50 | 16.07 | 4.94 | t = − 0.29c | 0.775 | ||
3 Months | 0.6 | 1.7 | 0.69 | 1.89 | 0.71 | 1.49 | ||||
3-Month change from baseline | −15.4 | 4.3 | t = 19.28b | 0.000 | −15.14 | 0.44 | −15.12 | 0.47 | F = 0.00d | 0.975 |
SANS | ||||||||||
Baseline | 4.8 | 6.9 | 3.47 | 6.56 | 5.93 | 7.43 | t = − 0.95c | 0.352 | ||
3 Months | 3.9 | 6.6 | 4.00 | 6.47 | 4.93 | 7.04 | ||||
3-Month change from baseline | −0.9 | 5.6 | z = 1.14a | 0.255 | −0.07 | 1.54 | −0.36 | 1.59 | F = 0.02d | 0.899 |